CFAP73
Cilia- and flagella-associated protein 73
Also known as: CCDC42B, CFA73_HUMAN, MIA2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A6NFT4
- Gene
- CFAP73
- Ensembl
- ENSG00000186710
- Chromosome
- 12
- Canonical length
- 308 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli fibrillar center,Vesicles
OverviewNCBI Gene
Predicted to enable dynein complex binding activity. Predicted to be involved in cilium movement and inner dynein arm assembly. Predicted to be located in axonemal doublet microtubule and motile cilium. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
308 residues, UniProt reviewed canonical sequence.
>A6NFT4|CFAP73
1 MAVPWEEYFR LALQEKLSTK LPEQAEDHVP PVLRLLEKRQ ELVDADQALQ AQKEVFRTKT
61 AALKQRWEQL EQKERELKGS FIRFDKFLQD SEARRNRALR RAAEERHQAG RREVEALRLW
121 TQLQELRREH ARLQRRLKRL EPCARLLEQA LELLPGFQEV PELVARFDGL AETQAALRLR
181 EREQLAELEA ARARLQQLRD AWPDEVLAQG QRRAQLQERL EAARERTLQW ESKWIQIQNT
241 AAEKTLLLGR SRMAVLNLFQ LVCQHQGQPP TLDIEDTEGQ LEHVKLFMQD LSAMLAGLGQ
301 AEPAAPASLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CFAP73 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 34 nTPM
Expression across tissuesHPA
Tissue
- fallopian tube: 34 nTPM
- choroid plexus: 30 nTPM
- hippocampal formation: 9.4 nTPM
- hypothalamus: 9.4 nTPM
- basal ganglia: 8 nTPM
- lung: 6.9 nTPM
Single-cell type
- respiratory ciliated cells: 556 nCPM
- ependymal cells: 503 nCPM
- fallopian tube ciliated cells: 477 nCPM
- epididymal efferent duct ciliated cells: 370 nCPM
- endometrial ciliated cells: 208 nCPM
- choroid plexus epithelial cells: 68 nCPM
Immune cell
- naive CD4 T-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- choroid plexus: 58 nTPM
- midbrain: 45 nTPM
- medulla oblongata: 39 nTPM
- spinal cord: 31 nTPM
- pons: 17 nTPM
- hypothalamus: 13 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.93
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CFAP73 as an antibody target. Whether an autoantibody or antibody against CFAP73 could matter depends on whether native CFAP73 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CFAP73 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CFAP73 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...